🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: * To demonstrate that re-challenge with an oxaliplatin ...
Status
Withdrawn
Location
Sanofi-Aventis Administrative Office
Start Date
2009-10
Trial ID
NCT00988897
Treatments Being Tested
This is a prospective, multicenter, randomized controlled, phase II study. ...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-06-01
Trial ID
NCT07621497
Patient therapy is tailored according to the molecular profile of the patie...
Status
Completed
Location
Georgetown University- Lombardi Comprehensive Cancer Center
Start Date
2012-12
Trial ID
NCT01888978
This study evaluates the investigational drug PledOx in the prevention of c...
Status
Terminated
Location
California Cancer Associates
Start Date
2018-11-07
Trial ID
NCT03654729
Treatments Being Tested
This randomized phase II trial studies how well combination chemotherapy an...
Status
Withdrawn
Location
USC Norris Comprehensive Cancer Center
Start Date
2015-11
Trial ID
NCT02413853
Preoperative 5FU based chemoradiotherapy is still the standard of treatment...
Status
Unknown
Location
Gastrointestinal Hospital, Sun Yatsen University
Start Date
2016-07
Trial ID
NCT02887313
Treatments Being Tested
This is a Phase I dose escalation trial to assess MTD of MK-3475 in combina...
Status
Terminated
Location
Huntsman Cancer Institute
Start Date
2015-01-23
Trial ID
NCT02268825
Treatments Being Tested
The purpose of this trial is to evaluate how well petosemtamab in combinati...
Status
Recruiting
Location
Vista Oncology
Start Date
2026-08-11
Trial ID
NCT07702032
Treatments Being Tested
To evaluate the efficacy and safety of immune checkpoint inhibitor-based co...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2026-03-01
Trial ID
NCT07446465
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Terminated
Location
START Midwest/Cancer & Hematology Centers of Western Michigan, PC
Start Date
2015-10
Trial ID
NCT02648711
Treatments Being Tested